We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

149 hedge funds and large institutions have $489M invested in Rigel Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 51 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

47% more capital invested

Capital invested by funds: $334M → $489M (+$155M)

17% more call options, than puts

Call options by funds: $2.51M | Put options by funds: $2.15M

8% more funds holding

Funds holding: 138 → 149 (+11)

0.01% more ownership

Funds ownership: 8.27% → 8.28% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

18% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 51

Holders
149
Holders Change
+11
Holders Change %
+7.97%
% of All Funds
2.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
42
Reduced
51
Closed
15
Calls
$2.51M
Puts
$2.15M
Net Calls
+$361K
Net Calls Change
+$1.07M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$6.74M
2
Goldman Sachs
Goldman Sachs
New York
+$5.71M
3
IAM
Ion Asset Management
Israel
+$5.3M
4
Norges Bank
Norges Bank
Norway
+$1.67M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.3M
2
Renaissance Technologies
Renaissance Technologies
New York
-$3.74M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3M
4
State Street
State Street
Massachusetts
-$2.15M
5
JGC
J. Goldman & Co
New York
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$2.66M -$62.4K -2,157 -3%
RG
27
Redmile Group
California
$2.61M – – –
ACM
28
AIGH Capital Management
Maryland
$2.46M +$2.03M +70,170 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.34M -$12.1K -417 -0.6%
Russell Investments Group
30
Russell Investments Group
United Kingdom
$2.1M -$957K -33,060 -36%
JP Morgan Chase
31
JP Morgan Chase
New York
$2.03M +$1.5M +51,764 +817%
Norges Bank
32
Norges Bank
Norway
$2.02M +$1.67M +57,790 New
ACM
33
Altium Capital Management
New York
$2M +$1.65M +57,103 New
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$1.71M -$200K -6,901 -12%
WMSA
35
Weiss Multi-Strategy Advisers
New York
$1.55M -$150K -5,191 -11%
SG Americas Securities
36
SG Americas Securities
New York
$1.53M +$1.04M +35,987 +470%
Charles Schwab
37
Charles Schwab
California
$1.46M +$48.7K +1,682 +4%
Wells Fargo
38
Wells Fargo
California
$1.45M -$404K -13,938 -25%
CM
39
CM Management
Florida
$1.4M +$1.16M +40,000 New
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.34M – – –
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.32M -$21.1K -730 -2%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$1.26M -$1.96M -67,550 -65%
IC
43
Ikarian Capital
Texas
$1.21M -$1.01M -35,000 -50%
CS
44
Credit Suisse
Switzerland
$1.18M -$135K -4,655 -12%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$1.14M +$271K +9,369 +39%
AG
46
Artal Group
Luxembourg
$1.12M – – –
UBS AM
47
UBS AM
Illinois
$1.07M +$610K +21,087 +222%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$903K +$7.73K +267 +1%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$808K -$83.1K -2,870 -11%
Citigroup
50
Citigroup
New York
$772K +$583K +20,129 +1,045%
1
2
3 4 5

RIGL Hedge Fund Activity: Q4 2020 in Review

149 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2020, worth a combined $489M — up 47% from $334M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RIGL positions and 15 closed out — a net gain of 11 holders — while 42 added to existing stakes and 51 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $6.74M. The largest seller was Wellington Management Group, cutting an estimated $7.3M.

  • 149 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2020, up from 138 in Q3 2020.
  • Funds reported $489M of Rigel Pharmaceuticals stock for Q4 2020, up 47% quarter-over-quarter.
  • 26 funds opened new Rigel Pharmaceuticals positions in Q4 2020 and 15 closed out, a net change of +11 holders.
  • The largest Rigel Pharmaceuticals buyer in Q4 2020 was Morgan Stanley, an estimated $6.74M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2020 was Wellington Management Group, an estimated $7.3M sold.

Based on aggregated 13F filings for Q4 2020.